BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fantini MC, Guadagni I. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Dig Liver Dis 2021;53:558-65. [PMID: 33541800 DOI: 10.1016/j.dld.2021.01.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Shahini A, Shahini A. Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome. J Cell Commun Signal . [DOI: 10.1007/s12079-022-00695-x] [Reference Citation Analysis]
2 Knauss A, Gabel M, Neurath MF, Weigmann B. The Memory T Cell “Communication Web” in Context with Gastrointestinal Disorders—How Memory T Cells Affect Their Surroundings and How They Are Influenced by It. Cells 2022;11:2780. [DOI: 10.3390/cells11182780] [Reference Citation Analysis]
3 Wang S, Godschalk R, Spooren C, de Graaf M, Jonkers D, van Schooten FJ. The role of diet in genotoxicity of fecal water derived from IBD patients and healthy controls. Food Chem Toxicol 2022;:113393. [PMID: 36049593 DOI: 10.1016/j.fct.2022.113393] [Reference Citation Analysis]
4 Loktionov A. Colon mucus in colorectal neoplasia and beyond. World J Gastroenterol 2022; 28(32): 4475-4492 [DOI: 10.3748/wjg.v28.i32.4475] [Reference Citation Analysis]
5 Xin J. Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges. Dig Liver Dis 2022:S1590-8658(22)00631-4. [PMID: 36002360 DOI: 10.1016/j.dld.2022.08.012] [Reference Citation Analysis]
6 Gubatan J, Boye TL, Temby M, Sojwal RS, Holman DR, Sinha SR, Rogalla SR, Nielsen OH. Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer. Microorganisms 2022;10:1371. [DOI: 10.3390/microorganisms10071371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang D, Xie B. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer. Eur J Med Res 2022;27:91. [PMID: 35698180 DOI: 10.1186/s40001-022-00720-0] [Reference Citation Analysis]
8 Nagao-Kitamoto H, Kitamoto S, Kamada N. Inflammatory bowel disease and carcinogenesis. Cancer Metastasis Rev 2022. [PMID: 35416564 DOI: 10.1007/s10555-022-10028-4] [Reference Citation Analysis]
9 Leite CDS, Bonafé GA, Carvalho Santos J, Martinez CAR, Ortega MM, Ribeiro ML. The Anti-Inflammatory Properties of Licorice (Glycyrrhiza glabra)-Derived Compounds in Intestinal Disorders. Int J Mol Sci 2022;23:4121. [PMID: 35456938 DOI: 10.3390/ijms23084121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bandaru SS, Boyilla R, Merchant N, Nagaraju GP, El-rayes B. Targeting T regulatory cells: their role in colorectal carcinoma progression and current clinical trials. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106197] [Reference Citation Analysis]
11 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Reference Citation Analysis]
12 Guo J, Liao M, Wang J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Commun Signal 2021;19:90. [PMID: 34479599 DOI: 10.1186/s12964-021-00771-6] [Reference Citation Analysis]
13 Kotelevets L, Chastre E. A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer. Cancers (Basel) 2021;13:4264. [PMID: 34503076 DOI: 10.3390/cancers13174264] [Reference Citation Analysis]
14 Sava A, Buron F, Routier S, Panainte A, Bibire N, Constantin SM, Lupașcu FG, Focșa AV, Profire L. Design, Synthesis, In Silico and In Vitro Studies for New Nitric Oxide-Releasing Indomethacin Derivatives with 1,3,4-oxadiazole-2-thiol Scaffold. Int J Mol Sci 2021;22:7079. [PMID: 34209248 DOI: 10.3390/ijms22137079] [Reference Citation Analysis]
15 Palko-Łabuz A, Maksymowicz J, Sobieszczańska B, Wikiera A, Skonieczna M, Wesołowska O, Środa-Pomianek K. Newly Obtained Apple Pectin as an Adjunct to Irinotecan Therapy of Colorectal Cancer Reducing E. coli Adherence and β-Glucuronidase Activity. Cancers (Basel) 2021;13:2952. [PMID: 34204704 DOI: 10.3390/cancers13122952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zeng S, Chen L, Sun Q, Zhao H, Yang H, Ren S, Liu M, Meng X, Xu H. Scutellarin ameliorates colitis-associated colorectal cancer by suppressing Wnt/β-catenin signaling cascade. Eur J Pharmacol 2021;906:174253. [PMID: 34118224 DOI: 10.1016/j.ejphar.2021.174253] [Reference Citation Analysis]
17 Sava A, Buron F, Routier S, Panainte A, Bibire N, Profire L. New nitric oxide-releasing indomethacin derivatives with 1,3-thiazolidine-4-one scaffold: Design, synthesis, in silico and in vitro studies. Biomed Pharmacother 2021;139:111678. [PMID: 33964802 DOI: 10.1016/j.biopha.2021.111678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]